Nationwide population-based epidemiologic study on cerebellar ataxia in Taiwan

European Neurology

Volumn 66, Issue 4, 2011, Pages 215-219

  Tsai, Tin Lun ^a   Liu, Chin San ^a,b   Lai, Chien Hsu ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cerebellar ataxia; Epidemiology; Incidence; Taiwan

Indexed keywords

ADULT; AGE SPECIFIC CARE; AGED; ARTICLE; CEREBELLAR ATAXIA; CHINESE MEDICINE; FEMALE; GROUPS BY AGE; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MALE; MEDICAL SERVICE; NEUROLOGY; OUTPATIENT CARE; PHYSICAL MEDICINE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; TAIWAN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CEREBELLAR ATAXIA; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RETROSPECTIVE STUDIES; SEX FACTORS; TAIWAN; YOUNG ADULT;

EID: 80054914583     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000331168     Document Type: Article

References (26)

1. Brusse E, Maat-Kievit JA, van Swieten JC: Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 2007;71:12-24. (Pubitemid 44921617)
2. Durr A: Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010;9:885-894.
3. Liu CS, Hsieh M, Chen YY, Lo MC: Machado-Joseph shoe. Mov Disord 2005;20:66-68. (Pubitemid 40277506)
4. Liu CS, Hsu HM, Cheng WL, Hsieh M: Clinical and molecular events in patients with Machado-Joseph disease under lamotrigine therapy. Acta Neurol Scand 2005;111:385-390.
5. Liu YF, Yang UC: SCA db: spinocerebellar ataxia candidate gene database. Bioinformatics 2004;20:2656-2661.
6. Lu MK, Shih HT, Huang KJ, Ziemann U, Tsai CH, Chang FC, et al.: Movement-related cortical potentials in patients with Machado-Joseph disease. Clin Neurophysiol 2008;119:1010-1019.
7. Soong BW, Lu YC, Choo KB, Lee HY: Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Arch Neurol 2001;58:1105-1109.
8. Tsai HF, Liu CS, Chen GD, Lin ML, Li C, Chen YY, et al.: Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3. J Clin Lab Anal 2003;17:195-200. (Pubitemid 37128660)
9. Tsai HF, Liu CS, Leu TM, Wen FC, Lin SJ, Liu CC, et al.: Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol Scand 2004;109:355-360.
10. Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC, et al.: Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 2004;65:209-214. (Pubitemid 38239752)
11. Yu YC, Kuo CL, Cheng WL, Liu CS, Hsieh M: Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. J Neurosci Res 2009;87:1884-1891.
12. Lin IS, Wu RM, Lee-Chen GJ, Shan DE, Gwinn-Hardy K: The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat Disord 2007;13:246-249. (Pubitemid 46603028)
13. Lee YC, Liu CS, Wu HM, Wang PS, Chang MH, Soong BW: The 'hot cross bun' sign in the patients with spinocerebellar ataxia. Eur J Neurol 2009;16:513-516.
14. Hsieh ML, Yang CY, Tsai HF, Chen YY, Li C, Li SY: The CAG repeats number of spinocerebellar ataxia type 1 gene in normal Taiwanese and in patients with dominant inherited ataxia. Proc Natl Sci Counc Repub China B 1997;21:91-95.
15. Hsieh M, Lin SJ, Chen JF, Lin HM, Hsiao KM, Li SY, et al.: Identification of the spinocerebellar ataxia type 7 mutation in Taiwan: application of PCR-based Southern blot. J Neurol 2000;247:623-629.
16. Hsieh M, Li SY, Tsai CJ, Chen YY, Liu CS, Chang CY, et al.: Identification of five spinocerebellar ataxia type 2 pedigrees in patients with autosomal dominant cerebellar ataxia in Taiwan. Acta Neurol Scand 1999;100:189-194. (Pubitemid 29376832)
17. Chung MY, Lu YC, Cheng NC, Soong BW: A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain 2003;126:1293-1299.
18. Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M, et al.: Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology 2010;74:839-845.
19. Albin RL: Dominant ataxias and Friedreich ataxia: an update. Curr Opin Neurol 2003;16:507-514.
20. Shibata-Hamaguchi A, Ishida C, Iwasa K, Yamada M: Prevalence of spinocerebellar degenerations in the Hokuriku district in Japan. Neuroepidemiology 2009;32:176-183.
21. Zhao Y, Tan EK, Law HY, Yoon CS, Wong MC, Ng I: Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in Singapore. Clin Genet 2002;62:478-481. (Pubitemid 36372781)
22. Lopez-Arlandis JM, Vilchez JJ, Palau F, Sevilla T: Friedreich's ataxia: an epidemiological study in Valencia, Spain, based on consanguinity analysis. Neuroepidemiology 1995;14:14-19.
23. Palau F, Espinos C: Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis 2006;1:47.
24. Trouillas P, Serratrice G, Laplane D, Rascol A, Augustin P, Barroche G, et al.: Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study. Arch Neurol 1995;52:456-460.
25. Mariotti C, Solari A, Torta D, Marano L, Fiorentini C, Di Donato S: Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology 2003;60:1676-1679. (Pubitemid 36618100)
26. Clauss R, Sathekge M, Nel W: Transient improvement of spinocerebellar ataxia with zolpidem. N Engl J Med 2004;351:511-512. (Pubitemid 38988605)